|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,461,833 |
|
|
Indirect Value
|
$12,984,280,034 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,066,741,867 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 38 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-28 |
4 |
S |
$4.45 |
$20,752 |
I/I |
(4,626) |
22,700 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-28 |
4 |
S |
$4.45 |
$77,618 |
I/I |
(17,302) |
92,414 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-28 |
4 |
S |
$4.45 |
$32,631 |
I/I |
(7,274) |
129,414 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-28 |
4 |
S |
$4.45 |
$486,610 |
I/I |
(108,472) |
1,650,021 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-28 |
4 |
S |
$4.45 |
$1,063,699 |
I/I |
(237,113) |
4,111,353 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$10,243 |
I/I |
(2,467) |
20,233 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$38,305 |
I/I |
(9,226) |
83,188 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$16,109 |
I/I |
(3,880) |
125,534 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$240,171 |
I/I |
(57,847) |
1,592,174 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$524,991 |
I/I |
(126,448) |
3,984,905 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-06-01 |
4 |
S |
$3.86 |
$11,579 |
I/I |
(2,992) |
17,241 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-06-01 |
4 |
S |
$3.86 |
$43,308 |
I/I |
(11,191) |
71,997 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-06-01 |
4 |
S |
$3.86 |
$18,212 |
I/I |
(4,706) |
120,828 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-06-01 |
4 |
S |
$3.86 |
$271,511 |
I/I |
(70,159) |
1,522,015 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-06-01 |
4 |
S |
$3.86 |
$593,536 |
I/I |
(153,371) |
3,831,534 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-10 |
4 |
B |
$19.48 |
$408,036 |
I/I |
20,934 |
3,690,370 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-10 |
4 |
B |
$19.48 |
$195 |
I/I |
10 |
194,115 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-11 |
4 |
B |
$19.36 |
$832,907 |
I/I |
43,012 |
3,733,382 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-11 |
4 |
B |
$19.36 |
$407 |
I/I |
21 |
194,136 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2009-08-11 |
4 |
B |
$10.75 |
$16,798,638 |
I/I |
1,562,664 |
10,246,673 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2009-08-11 |
4 |
B |
$10.75 |
$8,579 |
I/I |
798 |
481,890 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2009-08-11 |
4 |
B |
$10.75 |
$463,691 |
I/I |
43,134 |
214,613 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2009-08-11 |
4 |
B |
$10.75 |
$2,939,093 |
I/I |
273,404 |
4,626,213 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-12 |
4 |
B |
$19.70 |
$528,034 |
I/I |
26,808 |
3,760,190 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-12 |
4 |
B |
$19.70 |
$276 |
I/I |
14 |
194,150 |
2.17 |
- |
|
1397 Records found
|
|
Page 38 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|